 |
|
recombinant MAGE-3.1 antigen
A recombinant tumor-specific melanoma antigen. Vaccination with recombinant MAGE-3.1 antigen may induce a host immune response against MAGE-expressing cells, resulting in antitumoral T cell-mediated cytotoxicity. MAGE-expressing cells are found in melanoma, non-small-cell lung carcinoma (NSCLC), head and neck squamous cell carcinoma, transitional cell carcinoma of the bladder, and esophageal carcinoma. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)
| Synonyms: | | MAGE-3
MAGE-3.1
MAGEA3 | | |
|
|
